MDedge Cardiocast

87 Episodes

1. Top stories from the American Heart Association scientific sessions

   Published: 12/27/2019
2. Vascepa gains event-reduction nod; diabetes ups ischemic risks

   Published: 12/20/2019
3. Post-STEMI events less likely in women; bariatric surgery may lower stroke risk

   Published: 12/13/2019
4. New trick for old drug; Vascepa cost effective for CV reduction

   Published: 12/6/2019
5. Card Talk: TAVR and glass ceilings

   Published: 11/29/2019
6. ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special

   Published: 11/26/2019
7. Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF

   Published: 11/22/2019
8. Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk

   Published: 11/15/2019
9. How risk factors in childhood translate to CV outcomes in adulthood

   Published: 11/8/2019
10. Driving while defibrillating; hypertension holds greater risk in black patients

    Published: 11/1/2019
11. AFib hits Native Americans hard; TAVR shown durable, safe after 5 years

    Published: 10/25/2019
12. Practice changing prevention data from ESC 2019 Part II

    Published: 10/22/2019
13. Statins tied to skin, soft tissue infections; new Card Talk episode

    Published: 10/18/2019
14. Troponin protocol rapidly rules out MI; hidden risk of moderate aortic stenosis

    Published: 10/11/2019
15. Sun sets on longer DAPT after PCI; inactivity boosts post-MI risk

    Published: 10/4/2019
16. Cardiology dead last as women’s IM subspecialty choice

    Published: 9/27/2019
17. An antiplatelet surprise; Europeans go low in cholesterol guidelines

    Published: 9/20/2019
18. SGLT-2 inhibitors and more practice changing data from ESC 2019

    Published: 9/16/2019
19. Overweight BMI surpasses 'normal' and introducing the 'Card Talk' segment

    Published: 9/13/2019
20. Dapagliflozin transforms into heart failure drug

    Published: 9/6/2019